Cargando…
Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical live...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275512/ https://www.ncbi.nlm.nih.gov/pubmed/22273493 http://dx.doi.org/10.1186/1477-7819-10-22 |
_version_ | 1782223226144817152 |
---|---|
author | Ishii, Hiromichi Kobayashi, Takuma Kudou, Michihiro Nishimura, Masumi Toma, Atsushi Nakamura, Kenji Mazaki, Takeshi Itoh, Tsuyoshi |
author_facet | Ishii, Hiromichi Kobayashi, Takuma Kudou, Michihiro Nishimura, Masumi Toma, Atsushi Nakamura, Kenji Mazaki, Takeshi Itoh, Tsuyoshi |
author_sort | Ishii, Hiromichi |
collection | PubMed |
description | BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate. CONCLUSION: The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver. |
format | Online Article Text |
id | pubmed-3275512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32755122012-02-09 Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch Ishii, Hiromichi Kobayashi, Takuma Kudou, Michihiro Nishimura, Masumi Toma, Atsushi Nakamura, Kenji Mazaki, Takeshi Itoh, Tsuyoshi World J Surg Oncol Technical Innovations BACKGROUND: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma. CASE PRESENTATION: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate. CONCLUSION: The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver. BioMed Central 2012-01-25 /pmc/articles/PMC3275512/ /pubmed/22273493 http://dx.doi.org/10.1186/1477-7819-10-22 Text en Copyright ©2012 Ishii et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technical Innovations Ishii, Hiromichi Kobayashi, Takuma Kudou, Michihiro Nishimura, Masumi Toma, Atsushi Nakamura, Kenji Mazaki, Takeshi Itoh, Tsuyoshi Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title | Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title_full | Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title_fullStr | Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title_full_unstemmed | Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title_short | Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
title_sort | anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch |
topic | Technical Innovations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275512/ https://www.ncbi.nlm.nih.gov/pubmed/22273493 http://dx.doi.org/10.1186/1477-7819-10-22 |
work_keys_str_mv | AT ishiihiromichi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT kobayashitakuma anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT kudoumichihiro anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT nishimuramasumi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT tomaatsushi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT nakamurakenji anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT mazakitakeshi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch AT itohtsuyoshi anatomicalliversegmentectomy2forcombinedhepatocellularcarcinomaandcholangiocarcinomawithtumorthrombusinsegment2portalbranch |